Skip to main content

Table 2 Prevalence of HIV by patient characteristics, retreatment type among retreatment TB patients with known HIV test results at eleven RRHs, Uganda (n = 690)

From: Tuberculosis retreatment ‘others’ in comparison with classical retreatment cases; a retrospective cohort review

Characteristic Total Classical retreatment cases ‘Others’ retreatment cases P-value*
  HIV Positive   HIV Positive   HIV Positive
n (%) n (%) n (%)
Overall 690 424b (61.4) 374 200 (53.5) 316 224 (70.9) <0.001**
Sex        
 Male 492 284 (57.8) 289 145 (50.2) 203 139 (68.5) 0.022
 Female 198 140 (70.7) 85 55 (64.7) 113 85 (75.2)  
Age group, yearsa        
 <15 35 24 (68.6) 3 2 (66.7) 32 22 (68.8) <0.001
 15-44 488 316 (64.8) 277 157 (56.7) 211 159 (75.4)  
 >44 166 83 (50.0) 94 40 (42.6) 73 43 (58.9)  
Anatomical site        
 Pulmonary 650 391 (60.2) 374 200 (53.5) 276 191 (69.2) <0.001
 Extrapulmonary 40 33 (82.5) 0 0 (0.0) 40 33 (82.5)  
Treatment regimen        
 Retreatment: 2SRHZE/1RHZE/5RHE 553 329 (59.5) 357 192 (53.8) 196 137 (69.9) <0.001
 New:2RHZE/6EH or 2RHZ/4RH 106 73 (68.9) 16 8 (50.0) 90 65 (72.2)  
 Other regimen 31 22 (71.0) 1 0 (0.0) 30 22 (73.3)  
  1. *P-values are from either Pearson’s chi-squared test of Fischer’s exact tests for the difference between given characteristics and the type of retreatment among only HIV positive patients
  2. **P-value from Z-test for two proportions
  3. a1 patient had missing data on this variable
  4. bCotrimoxazole preventive therapy and antiretroviral treatment were documented among 385 (91 %) and 221 (52 %) of all HIV positive TB retreatment patients respectively